|
C1ORF210 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72906133855122E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.83350034943919E-10 |
| Normal-vs-Stage2 |
1.5454799999981E-05 |
| Normal-vs-Stage3 |
2.13040030061507E-10 |
| Normal-vs-Stage4 |
1.39199762827502E-11 |
| Stage1-vs-Stage2 |
1.357620E-01 |
| Stage1-vs-Stage3 |
6.435300E-04 |
| Stage1-vs-Stage4 |
3.056800E-03 |
| Stage2-vs-Stage3 |
1.798580E-01 |
| Stage2-vs-Stage4 |
7.485700E-02 |
| Stage3-vs-Stage4 |
4.486600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63768998362457E-12 |
| Normal-vs-AfricanAmerican |
2.33490000000058E-05 |
| Normal-vs-Asian |
1.591990E-02 |
| Caucasian-vs-AfricanAmerican |
5.420400E-02 |
| Caucasian-vs-Asian |
2.123000E-01 |
| AfricanAmerican-vs-Asian |
1.083620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80340187228012E-11 |
| Normal-vs-Female |
3.56381590904675E-14 |
| Male-vs-Female |
8.382000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.97883939737176E-12 |
| Normal-vs-Extreme_Weight |
3.32667227098682E-12 |
| Normal-vs-Obese |
3.77240000348777E-08 |
| Normal-vs-Extreme_Obese |
5.948200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.001800E-01 |
| Normal_Weight-vs-Obese |
1.247610E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.004200E-02 |
| Extreme_Weight-vs-Obese |
6.432800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.021790E-02 |
| Obese-vs-Extreme_Obese |
5.390300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.829540E-04 |
| Normal-vs-Age(41-60Yrs) |
1.69210001566E-09 |
| Normal-vs-Age(61-80Yrs) |
2.1360690993788E-13 |
| Normal-vs-Age(81-100Yrs) |
6.356000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.868300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.106210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.215000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.498600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.305400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.595000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.10199999967276E-07 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
1.62458935193399E-12 |
| Normal-VS-Unclassified PRCC |
1.97710000005014E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.84780000481666E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.66056057793185E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
2.539400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.13350000391566E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
5.423000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.65519999999875E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.00062189037453E-12 |
| Normal-vs-N1 |
<1E-12 |
| Normal-vs-N2 |
4.7208004172461E-10 |
| N0-vs-N1 |
1.034060E-02 |
| N0-vs-N2 |
5.033900E-02 |
| N1-vs-N2 |
2.929800E-01 |
|
|
